|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,860.00 JPY | -4.65% |
|
-3.41% | +14.70% |
| 06-04 | Organo Corporation Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-13 | Organo Corp - to conduct 5-for-1 stock split for shareholders as of September 30 | RE |
Company Valuation: Organo Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 116,036 | 165,430 | 353,770 | 292,805 | 625,823 | 716,635 | - | - |
| Change | - | 42.57% | 113.85% | -17.23% | 113.73% | 14.51% | - | - |
| Enterprise Value (EV) 1 | 111,466 | 182,891 | 372,593 | 298,611 | 629,170 | 713,433 | 686,651 | 653,406 |
| Change | - | 64.08% | 103.72% | -19.86% | 110.7% | 13.39% | -3.75% | -4.84% |
| P/E | 12.6x | 14.1x | 20.4x | 12.1x | 22x | 22.9x | 20.7x | 19.5x |
| PBR | 1.53x | 1.92x | 3.47x | 2.42x | 4.38x | 4.36x | 3.87x | 3.41x |
| PEG | - | 0.5x | 0.4x | 0.3x | 1.3x | 2.3x | 1.9x | 3.11x |
| Capitalization / Revenue | 1.04x | 1.25x | 2.35x | 1.79x | 3.52x | 3.51x | 3.25x | 3.1x |
| EV / Revenue | 0.99x | 1.38x | 2.48x | 1.83x | 3.54x | 3.49x | 3.12x | 2.82x |
| EV / EBITDA | - | 10.7x | 15.2x | 9.04x | 15.9x | 15.9x | 13.6x | 12.2x |
| EV / EBIT | 10.3x | 12x | 16.5x | 9.6x | 16.7x | 17x | 14.8x | 13.2x |
| EV / FCF | 15.1x | -9.14x | 161x | 16.3x | 65.7x | 26.4x | 23.9x | 20.6x |
| FCF Yield | 6.64% | -10.9% | 0.62% | 6.13% | 1.52% | 3.79% | 4.19% | 4.87% |
| Dividend per Share 2 | 40 | 62 | 102 | 160 | 200 | 225 | 243.3 | 256.7 |
| Rate of return | 1.58% | 1.72% | 1.32% | 2.51% | 1.47% | 1.44% | 1.56% | 1.65% |
| EPS 2 | 200.7 | 255.8 | 376.9 | 525.4 | 617.7 | 680 | 752.5 | 799.6 |
| Distribution rate | 19.9% | 24.2% | 27.1% | 30.5% | 32.4% | 33.1% | 32.3% | 32.1% |
| Net sales 1 | 112,069 | 132,426 | 150,356 | 163,269 | 177,654 | 204,133 | 220,233 | 231,333 |
| EBITDA 1 | - | 17,036 | 24,554 | 33,045 | 39,629 | 44,950 | 50,600 | 53,500 |
| EBIT 1 | 10,850 | 15,212 | 22,544 | 31,120 | 37,648 | 41,967 | 46,433 | 49,333 |
| Net income 1 | 9,210 | 11,730 | 17,310 | 24,150 | 28,401 | 31,267 | 34,600 | 36,767 |
| Net Debt 1 | -4,570 | 17,461 | 18,823 | 5,806 | 3,347 | -3,202 | -29,984 | -63,229 |
| Reference price 2 | 2,532.50 | 3,605.00 | 7,700.00 | 6,370.00 | 13,610.00 | 15,585.00 | 15,585.00 | 15,585.00 |
| Nbr of stocks (in thousands) | 45,819 | 45,889 | 45,944 | 45,966 | 45,983 | 45,982 | - | - |
| Announcement Date | 5/12/22 | 5/12/23 | 5/13/24 | 5/13/25 | 5/13/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 23.27x | 3.55x | 16.11x | 1.42% | 4.49B | ||
| 22.91x | 2.95x | 15.78x | 1.35% | 10.35B | ||
| 60.81x | 3.95x | 24.89x | - | 4.7B | ||
| 35.29x | - | - | - | 1.64B | ||
| 48.61x | 3.17x | 27.23x | - | 936M | ||
| 72.77x | - | - | - | 756M | ||
| Average | 43.94x | 3.40x | 21.00x | 1.38% | 3.81B | |
| Weighted average by Cap. | 34.36x | 3.32x | 18.47x | 1.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6368 Stock
- Valuation Organo Corporation
Select your edition
All financial news and data tailored to specific country editions
















